We have investigated the expression of platelet-derived endothelial-cell growth factorkhymidine phosphorylase (PD-ECGF/dThdPase) in human breast-cancer tissues by the immunocytochemical method using anti-PD-ECGF/ dThdPase monoclonal antibody. Out of I00 invasive-ductal-carcinoma tissue samples, 39 (
Specific Enhanced Expression of Platelet-Derived Endothelial Cell Growth Factor in Submucosa of Human Colorectal Cancer
โ Scribed by Tadashi Nozawa; Takumo Enomoto; Yoshitomo Koshida; Yuichi Sato; Masaru Kuranami
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 393 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Angiogenesis is a prerequisite to cancer growth and metastasis and is induced by a variety of angiogenic factors, including platelet-derived endothelial cell growth factor (pdecgf). the authors investigated the expression of pdecgf in 58 initial primary bladder carcinomas. ## Method
## BACKGROUND. Platelet-derived endothelial cell growth factor (PD-ECGF) is an angiogenic factor that has potent chemotactic activity for endothelial cells. Although it is expressed in the majority of colorectal tumors, and some reports suggest that its high expression is related to poor prognosis,